Boston University_Site number 137 — Boston, Massachusetts

Boston University_Site number 137 is a clinical research site located in Boston, Massachusetts, United States 02118.

Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.

Boston University_Site number 137 has participated in 1 clinical trials.

Therapeutic areas: System; Sclerosis, Diffuse Cutaneous Systemic Sclerosis.

Sponsors: Kadmon, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

Sponsor Feasibility Report

Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Boston University_Site number 137?

Boston University_Site number 137 has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Boston University_Site number 137 conducted?

Boston University_Site number 137 has 1 clinical trials on record. Their work covers System; Sclerosis, Diffuse Cutaneous Systemic Sclerosis.

Is Boston University_Site number 137 accredited by Crixeo Clinical Trials?

Boston University_Site number 137 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Boston University_Site number 137?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.